Request Deal Involvement

Huadong Medicine completed the acquisition of Sinclair Pharma for $222m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Eversheds Sutherland

legal advisors

Eversheds Sutherland

Peel Hunt

financial advisors

Peel Hunt

Peel Hunt

brokers

Peel Hunt

FTI Consulting

pr advisors

FTI Consulting

Rothschild & Co

financial advisors

Rothschild & Co

Jones Day

legal advisors

Jones Day

Piper Jaffray

financial advisors

Piper Jaffray

or

Principals

SINCLAIR PHARMA PLC

target

SINCLAIR PHARMA PLC

HUADONG MEDICINE CO LTD

bidder

HUADONG MEDICINE CO LTD

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Huadong Medicine completed the acquisition of Sinclair Pharma for $222m.